LONG TERM FOLLOW-UP OF AGGRESSIVE MEDICAL THERAPY OF ACCELERATED HYPERTENSION WITH AZOTEMIA. = SURVEILLANCE A LONG TERME DU TRAITEMENT MEDICAL AGRESSIF DE L'HYPERTENSION ACCELEREE AVEC AZOTEMIEDAVIDOV M; MROCZEK W; GAVRILOVICH L et al.1975; ANGIOLOGY; U.S.A.; DA. 1975; VOL. 26; NO 5; PP. 396-407; BIBL. 1 P.Article

Low-dose Bisoprolol/hydrochlorothiazide : an option in first-line, antihypertensive treatmentZACHARIAH, P. K; MESSERLI, F. H; MROCZEK, W et al.Clinical therapeutics. 1993, Vol 15, Num 5, pp 779-787, issn 0149-2918Article

Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension : a multicenter trialMROCZEK, W. J.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S147-S149, issn 0160-2446, SUP2Conference Paper

Nitrendipine monotherapy in severe hypertensionMROCZEK, W. J; BURRIS, J. F.Angiology. 1988, Vol 39, Num 1, pp 81-86, issn 0003-3197, 2Article

Comparison of ramipril and enalapril in patients with essential hypertensionRUDDY, M. C; MROCZEK, W. J.Pharmacotherapy. 1993, Vol 13, Num 3, pp 224-228, issn 0277-0008Conference Paper

Dose-finding study of cilazapril (inhibace®) in patients with uncomplicated essential hypertensionMROCZEK, W. J; KLEIN, J; BURRIS, J. F et al.Clinical and experimental hypertension. Part A, Theory and practice. 1991, Vol 13, Num 8, pp 1415-1432, issn 0730-0077Article

Pentoxifylline in the treatment of vascular inpotenceALLENBY, K. S; BURRIS, J. F; MROCZEK, W. J et al.Angiology. 1991, Vol 42, Num 5, pp 418-420, issn 0003-3197Article

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker : Results from a 10-week, double-blind, placebo-controlled, dose-titration studyNEUTEL, J. M; BUCKALEW, V; CHRYSANT, S. G et al.The American heart journal. 1999, Vol 137, Num 1, pp 118-125, issn 0002-8703Article

Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertensionRAM, C. V. S; AMES, R. P; APPLEGATE, W. B et al.Clinical cardiology (Mahwah, NJ). 1994, Vol 17, Num 5, pp 251-256, issn 0160-9289Article

Comparison of the antihypertensive effects of betaxolol to atenololMROCZEK, W. J; BURRIS, J. F; HOGAN, L. B et al.The American journal of cardiology. 1988, Vol 61, Num 10, pp 807-811, issn 0002-9149Article

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and II systemic hypertensionFRISHMAN, W. H; BURRIS, J. F; MROCZEK, W. J et al.Journal of clinical pharmacology. 1995, Vol 35, Num 2, pp 182-188, issn 0091-2700Article

Remission of mild to moderate hypertension after treatment with carteolol, a β-adrenoceptor blocker with intrinsic sympathomimetic activityGILES, T. D; SANDER, G. E; ROFFIDAL, L et al.Archives of internal medicine (1960). 1988, Vol 148, Num 8, pp 1725-1728, issn 0003-9926, 4 p.Article

A multifactorial trial design to assess combination therapy in hypertensionFISHMAN, W. H; BRYZINSKI, B. S; COULSON, L. R et al.Archives of internal medicine (1960). 1994, Vol 154, Num 13, pp 1461-1468, issn 0003-9926Article

Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combinationBURRIS, J. F; DAVIDOV, M. E; JENKINS, P et al.Archives of internal medicine (1960). 1989, Vol 149, Num 11, pp 2437-2441, issn 0003-9926, 5 p.Article

Labetalol and hydrochlorothiazide in hypertensionWRIGHT, J. T. JR; GOODMAN, R. P; CALDERONE, P et al.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 1, pp 24-27, issn 0009-9236Article

Carteolol treatment of essential hypertension: a long-term study of safety and efficacyLUTHER, R. R; MAURATH, C. J; MOYER, R et al.Journal of international medical research. 1986, Vol 14, Num 4, pp 175-184, issn 0300-0605Article